Skip to content

A clinical study to evaluate the combined efficacy of Nasya (nasal medication) and Uttarabhaktika snehapana (intake of medicated ghee after food) in restricted shoulder range of movements and shoulder pain

Pre and Post-test clinical study to evaluate the combined efficacy of Nasya and Uttarabhaktika snehapana in Apabahuka

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009189
Enrollment
30
Registered
2017-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Restricted shoulder joint movements with pain

Interventions

Intervention1: Nasya and Uttarabhaktika snehapana in Apabahuka: 7 days Nasya as ipd intervention and 7 days Uttarabhaktika snehapana as OPD level intervention total no of intervention will be 14 d

Sponsors

Sandu Pillai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient fit for brihmana nasya and snehapana 2.patients having signs and symptoms of Apabahuka ie bahupraspandithahara(restricted movements)and amsasandhishoola (pain) 3.chronicity less than five years

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating mothers 2.Patient undergoing steroid therapy 3.Patients with history of fracture of shoulder 4.Diabetes mellitus

Design outcomes

Primary

MeasureTime frame
goniometer reading pre and post VAS(visual analog scale) for pain pre and post DASH and simple shoulder test (Questionnaire Pre and Post )Timepoint: goniometer reading, VAS(visual analog scale, DASH and simple shoulder test Questionnaire - assessed on 1st day and 14th day of treatment.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr James chacko

Amrita School of Ayurveda,Amrita Vishwa Vidyapeetam

drjames.2008@rediffmail.com9495191191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026